(Q36671526)

15 August 2017

Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status (English)

1 reference

15 August 2017

1 reference

5

1 reference

15 August 2017

6

J L Hopper

1 reference

15 August 2017

3

M C Southey

1 reference

15 August 2017

2

G S Dite

1 reference

15 August 2017

M R E McCredie

1

1 reference

15 August 2017

D J Venter

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

15 August 2017

3

1 reference

British Journal of Cancer

inferred from page(s)

published in

1 reference

15 August 2017

89

1 reference

15 August 2017

9

1 reference

15 August 2017

1661-1663

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601293

15 August 2017

0 references

cites work

Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394423

Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394423

Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394423

Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. A univariate and multivariate analysis of 3089 Japanese patients with breast cancer from the Study Group for the Japanese Breast Cancer Society on

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394423

Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394423

The shape of age-incidence curves of female breast cancer by hormone-receptor status.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394423

Familial Risks, Early-Onset Breast Cancer, and BRCA1 and BRCA2 Germline Mutations

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601293

Background, rationale and protocol for a case-control-family study of breast cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601293

Breast cancer in Australian women under the age of 40

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601293

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14583766

12 December 2020

inferred from PubMed ID database lookup

Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14583766

12 December 2020

inferred from PubMed ID database lookup

Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14583766

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/SJ.BJC.6601293

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

14583766

1 reference